[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336351-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336351-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comprehensive-analysis-of-the-relationship-between-ubiquitin-specific-protease-21-usp21-and-prognosis-in-colorectal-cancer-abstract","Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis in colorectal cancer - Abstract","","Ubiquitin-specific protease USP21 is investigated for its roles in colorectal cancer (CRC) immunosurveillance, immunotherapy response, and clinical prognosis. Differential USP21 expression is assessed in CRC versus normal tissues using multiple public databases, then validated in clinical samples by qRT-PCR and immunohistochemistry. Cellular and gene expression analyses evaluate CRC growth, signaling, cytokine levels, and tumor microenvironment (TME) immune infiltration, including impacts on responses to immunotherapy and chemotherapy. Results show USP21 is upregulated in CRC, associates with poor prognosis, and links low USP21 to immune activation, elevated TMB and PD-L1, and improved therapy responsiveness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comprehensive-analysis-of-the-relationship-between-ubiquitin-specific-protease-21-usp21-and-prognosis-in-colorectal-cancer-abstract/336351/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-the-relationship-between-ubiquitin-specific-protease-21-usp21-and-prognosis-in-colorectal-cancer-abstract/336351.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this study on USP21 in colorectal cancer?","Question",{"text":63,"@type":64},"To determine how USP21 relates to prognosis, tumor microenvironment immune infiltration, and response to immunotherapy and chemotherapy in CRC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was USP21 expression measured and validated?",{"text":68,"@type":64},"USP21 differential expression was analyzed using multiple public databases, then validated in clinical samples using qRT-PCR and immunohistochemistry (IHC).",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic implications does USP21 expression suggest?",{"text":72,"@type":64},"Low USP21 is associated with an immune-activated TME, higher tumor mutational burden and PD-L1 expression, and better responsiveness to immunotherapy and chemotherapeutic drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336351,1790198207,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Cancer Immunology, Immunotherapy (2024) 73:156 [https://doi.org/10.1007/s00262-024-03731-4](https://doi.org/10.1007/s00262-024-03731-4)  \nComprehensive analysis of the relationship between ubiquitin‑specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer  \nHaihang Nie1,2,5 · Yali Yu1,2,5 · Fan Wang1,2,5 · Xing Huang1,2,5 · Haizhou Wang1,2,5 · Jing Wang1,2,5 · Mi Tao4 · Yumei Ning1,2,5 · JingKai Zhou1,2,5 · Qiu Zhao1,2,5 · Fei Xu1,2,5 · Jun Fang1,2,3,5  \nReceived: 1 April 2024 / Accepted: 13 May 2024 / Published online: 4 June 2024 © The Author(s) 2024  \nAbstract  \nBackground Ubiquitin-specific proteases family is crucial to host immunity against pathogens. However, the correlations between USP21 and immunosurveillance and immunotherapy for colorectal cancer (CRC) have not been reported. Methods The differential expression of USP21 between CRC tissues and normal tissues was analyzed using multiple public databases. Validation was carried out in clinical samples through qRT-PCR and IHC. The correlation between USP21 and the prognosis, as well as clinical pathological characteristics of CRC patients, was investigated. Moreover, cell models were established to assess the influence of USP21 on CRC growth and progression, employing CCK-8 assays, colony formation assays, and wound-healing assays. Subsequently, gene set variation analysis (GSVA) was used to explore the potential biological functions of USP21 in CRC. The study also examined the impact of USP21 on cytokine levels and immune cell infiltration in the tumor microenvironment (TME) . Finally, the effect of USP21 on the response to immunotherapy and chemotherapy in CRC was analyzed.  \nResults The expression of USP21 was significantly upregulated in CRC. High USP21 is correlated with poor prognosis in CRC patients and facilitates the proliferation and migration capacities of CRC cells. GSVA indicated an association between low USP21 and immune activation. Moreover, low USP21 was linked to an immune-activated TME, characterized by high immune cell infiltration. Importantly, CRC with low USP21 exhibited higher tumor mutational burden, high PD-L1 expression, and better responsiveness to immunotherapy and chemotherapeutic drugs.  \nConclusion This study revealed the role of USP21 in TME, response to therapy, and clinical prognosis in CRC, which provided novel insights for the therapeutic application in CRC.  \nKeywords Ubiquitin · USP21 · Colorectal cancer · Tumor microenvironment · Immunotherapy · Prognosis  \nHaihang Nie, Yali Yu, Fan Wang, Xing Huang, Haizhou Wang, and Jing Wang these authors contributed equally to this study.  \n* Qiu Zhao [zhaoqiuwhu@163.com](zhaoqiuwhu@163.com)  \n* Fei Xu [2017103030003@whu.edu.cn](2017103030003@whu.edu.cn)  \n* Jun Fang[xhfangjun@163.com](xhfangjun@163.com)  \n1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China  \nIntroduction  \nColorectal cancer (CRC) is the third most common cause of cancer mortality worldwide with more than 1.85 million cases and 850 000 deaths annually [1] . While there exists a plethora  \n2 Hubei Provincial Clinical Research Center for Intestinal and Colorectal Diseases, Wuhan 430071, China  \n3 Department of General Medical, Zhongnan Hospital of Wuhan University, Wuhan 430071, China  \n4 Department of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China  \n5 Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China  \nof treatments for colorectal cancer, including surgery, radiotherapy, chemotherapy, and immunotherapy, their efficacy has significantly improved over time. Nonetheless, long-term benefits for patients remain largely unchanged [2–4] . Immunotherapy has garnered substantial interest in cancer treatment research due to its noted advantages, such as high efficacy and minimal side effects. However, a considerable number of patients still exhibit","cbCaihJZi03VeBww","https://ap.wps.com/l/cbCaihJZi03VeBww","pdf",16929961,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is the main objective of this study on USP21 in colorectal cancer?\",\"answer\":\"To determine how USP21 relates to prognosis, tumor microenvironment immune infiltration, and response to immunotherapy and chemotherapy in CRC.\"},{\"question\":\"How was USP21 expression measured and validated?\",\"answer\":\"USP21 differential expression was analyzed using multiple public databases, then validated in clinical samples using qRT-PCR and immunohistochemistry (IHC).\"},{\"question\":\"What therapeutic implications does USP21 expression suggest?\",\"answer\":\"Low USP21 is associated with an immune-activated TME, higher tumor mutational burden and PD-L1 expression, and better responsiveness to immunotherapy and chemotherapeutic drugs.\"}]","Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis in colorectal cancer - Abstract | PDF",1790014667,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c157cd0c8a705b0b6e6c6a0d0a81af9.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77357ce513928622212f4583309ef6b6.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf2f4ddf8ad76e02c0aa4ee6bcdb427b.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ac443048342b0ea6a89af9db58a2807.webp",980,1301]